Daiwa Securities Group’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $664K | Buy |
5,145
+412
| +9% | +$59.2K | ﹤0.01% | 853 |
|
|
2025
Q4 | $675K | Buy |
4,733
+197
| +4% | +$26.4K | ﹤0.01% | 842 |
|
|
2025
Q3 | $544K | Sell |
4,536
-34
| -0.7% | -$4.31K | ﹤0.01% | 857 |
|
|
2025
Q2 | $604K | Buy |
4,570
+1,911
| +72% | +$259K | ﹤0.01% | 822 |
|
|
2025
Q1 | $369K | Hold |
2,659
| – | – | ﹤0.01% | 877 |
|
|
2024
Q4 | $413K | Sell |
2,659
-15,283
| -85% | -$2.58M | ﹤0.01% | 872 |
|
|
2024
Q3 | $3.27M | Sell |
17,942
-1,430
| -7% | -$212K | 0.02% | 464 |
|
|
2024
Q2 | $2.3M | Sell |
19,372
-121
| -0.6% | -$12.7K | 0.01% | 519 |
|
|
2024
Q1 | $2.09M | Sell |
19,493
-9,119
| -32% | -$907K | 0.01% | 544 |
|
|
2023
Q4 | $2.85M | Buy |
28,612
+350
| +1% | +$34.2K | 0.02% | 428 |
|
|
2023
Q3 | $3.36M | Sell |
28,262
-3,464
| -11% | -$517K | 0.02% | 366 |
|
|
2023
Q2 | $5.65M | Buy |
31,726
+2,466
| +8% | +$452K | 0.04% | 246 |
|
|
2023
Q1 | $4.83M | Sell |
29,260
-7,595
| -21% | -$1.31M | 0.03% | 280 |
|
|
2022
Q4 | $5.8M | Buy |
36,855
+376
| +1% | +$57.2K | 0.04% | 233 |
|
|
2022
Q3 | $5.49M | Buy |
36,479
+6,268
| +21% | +$1.04M | 0.05% | 225 |
|
|
2022
Q2 | $4.97M | Buy |
30,211
+5,154
| +21% | +$992K | 0.04% | 252 |
|
|
2022
Q1 | $5.58M | Buy |
25,057
+14,490
| +137% | +$3.25M | 0.04% | 264 |
|
|
2021
Q4 | $2.51M | Buy |
10,567
+6,925
| +190% | +$1.62M | 0.01% | 449 |
|
|
2021
Q3 | $850K | Buy |
3,642
+22
| +0.6% | +$4.61K | 0.01% | 721 |
|
|
2021
Q2 | $745K | Sell |
3,620
-540
| -13% | -$111K | 0.01% | 736 |
|
|
2021
Q1 | $855K | Sell |
4,160
-255
| -6% | -$53.8K | 0.01% | 677 |
|
|
2020
Q4 | $947K | Sell |
4,415
-665
| -13% | -$129K | 0.01% | 586 |
|
|
2020
Q3 | $928K | Buy |
5,080
+694
| +16% | +$131K | 0.01% | 524 |
|
|
2020
Q2 | $885K | Hold |
4,386
| – | – | 0.02% | 400 |
|
|
2020
Q1 | $885K | Sell |
4,386
-587
| -12% | -$113K | 0.01% | 506 |
|
|
2019
Q4 | $931K | Sell |
4,973
-899
| -15% | -$155K | 0.01% | 546 |
|
|
2019
Q3 | $937K | Sell |
5,872
-621
| -10% | -$124K | 0.01% | 515 |
|
|
2019
Q2 | $1.64M | Sell |
6,493
-1,076
| -14% | -$249K | 0.01% | 382 |
|
|
2019
Q1 | $1.81M | Sell |
7,569
-1,667
| -18% | -$400K | 0.02% | 354 |
|
|
2018
Q4 | $2.12M | Sell |
9,236
-198
| -2% | -$48.8K | 0.02% | 312 |
|
|
2018
Q3 | $2.67M | Sell |
9,434
-3,460
| -27% | -$1.01M | 0.02% | 322 |
|
|
2018
Q2 | $3.79M | Sell |
12,894
-3,730
| -22% | -$1.02M | 0.03% | 277 |
|
|
2018
Q1 | $4.2M | Buy |
16,624
+175
| +1% | +$41.1K | 0.03% | 253 |
|
|
2017
Q4 | $3.55M | Buy |
+16,449
| New | +$3.33M | 0.03% | 286 |
|
Other funds holding ICUI
VPM
VCM
RRAM
Daiwa Securities Group's ICUI Position: Q1 2026 in Review
Daiwa Securities Group increased its ICU Medical (ICUI) stake by 8.7% in Q1 2026, buying an estimated $59.2K and bringing the position to 5,145 shares worth $664K. The position accounts for ﹤0.01% of the portfolio, ranked #853.
Daiwa Securities Group first reported a position in ICUI in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.8M in Q4 2022. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- Daiwa Securities Group held 5,145 shares of ICU Medical worth $664K as of Q1 2026.
- Daiwa Securities Group bought 412 ICU Medical shares in Q1 2026, an estimated $59.2K.
- ICU Medical made up ﹤0.01% of Daiwa Securities Group's portfolio in Q1 2026, its #853 holding.
- Daiwa Securities Group first reported a position in ICU Medical in Q4 2017 and has held it in 34 quarters since.
- Daiwa Securities Group's ICU Medical position peaked at $5.8M in Q4 2022.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.